2020/21 Publications

Between 1st April 2020 - 31st March 2021, the following articles were published by researchers using the NIHR Sheffield Clinical Research Facility (CRF).

Accident & Emergency

Anaesthesia & Operating Services

Cardiovascular

Clinical Immunology

Whole-genome sequencing of a sporadic primary immunodeficiency cohort (STH18558: Whole-genome sequencing of a sporadic primary immunodeficiency cohort)

Critical Care

Diabetes & Endocrinology

Haematology

Infectious Diseases

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (STH21355: RECOVERY)

Dexamethasone in Hospitalized Patients with Covid-19 (STH21355: RECOVERY)

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 (STH21355: RECOVERY)

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (STH21355: RECOVERY)

RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials (STH21355: RECOVERY)

Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series (STH21358: GILEAD SEVERE)

Patients With Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale During a Global Pandemic (STH21358: GILEAD SEVERE)

Remdesivir for Severe Coronavirus Disease 2019 (COVID19) Versus a Cohort Receiving Standard of Care (STH21358: GILEAD SEVERE)

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 (STH21358: GILEAD SEVERE)

Antibody evasion by the P.1 strain of SARS-CoV-2 (STH21413: COV002)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial (STH21413: COV002)

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant (STH21413: COV002)

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (STH21413: COV002)

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (STH21413: COV002)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (STH21413: COV002)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (STH21413: COV002)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (STH21413: COV002)

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (STH21413: COV002)

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (STH21413: COV002)

Medical Imaging & Medical Physics

Metabolic Bone

Neurological

Fit for purpose? A cross-sectional study to evaluate the acceptability and usability of HeadUp, a novel neck support collar for neurological neck weakness (STH15573: Head Up)

Deficits in Mitochondrial Spare Respiratory Capacity Contribute to the Neuropsychological Changes of Alzheimer’s Disease (STH17001: Improving detection and prevention of cognitive decline in ageing)

Obesity and Brain Vulnerability in Normal and Abnormal Aging: A Multimodal MRI Study (STH17001: Improving detection and prevention of cognitive decline in ageing)

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT (STH17249: MS-SMART)

Psychological and demographic characteristics of 368 patients with dissociative seizures: data from the CODES cohort (STH18295: CODES)

A Multifactorial Model of Multiple Sclerosis Gait and Its Changes Across Different Disability Levels (STH18829: MS SMART - ADD ON)

Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting (STH18829: MS SMART - ADD ON)

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS (STH19145: SOD1)

Value of systematic genetic screening of patients with amyotrophic lateral sclerosis (STH19219: AMBRoSIA)

Caregiver Delivered Sensory Electrical Stimulation for Post Stroke Upper Limb Spasticity: A Single Blind Crossover Randomized Feasibility Study (STH19263: MUSTS)

Ofatumumab versus Teriflunomide in Multiple Sclerosis (STH19613: Asclepios)

Obstetrics

Respiratory

Rheumatology

Urology